Photo of Katri Koli
  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

1991 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Description of research and teaching

Our research is directed towards understanding how growth factors in the extracellular environment regulate growth and differentiation. In particular, the targeting and activation of the TGF-β/BMP family growth factors and their role in normal functions as well as in the pathogenesis of diseases such as fibrosis and cancer, is of interest. In our research we analyze human tissue biopsies, use in vitro cell culture and in vivo experimental mouse models as well as high throughput technologies.

Fields of Science

  • 3111 Biomedicine
  • 118 Biological sciences
  • TGF-beta/BMP family signaling
  • 1182 Biochemistry, cell and molecular biology

International and National Collaboration Publications and projects within past five years.

Publications 1991 2019

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry

Kaunisto, J., Salomaa, E-R., Hodgson, U. A., Kaarteenaho, R., Kankaanranta, H., Koli, K., Vahlberg, T. & Myllärniemi, M., 2019, In : ERJ Open Research. 5, 3

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Malignant pleural mesothelioma in Finland: regional and gender variation

Laaksonen, S., Ilonen, I., Kuosma, E., Sutinen, E., Wolff, H., Vehmas, T., Husgafvel-Pursiainen, K., Salo, J. A., Koli, K., Räsänen, J. & Myllärniemi, M., 2019, In : Acta Oncologica. 58, 1, p. 38-44 7 p.

Research output: Contribution to journalArticleScientificpeer-review

Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo

Li, C., Rezov, V., Joensuu, E., Vartiainen, V., Rönty, M., Yin, M., Myllärniemi, M. & Koli, K., 3 Jul 2018, In : Scientific Reports. 8, 14 p., 10070.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice

Vartiainen, V., Raula, J., Bimbo, L. M., Viinamäki, J., Backman, J. T., Ugur, N., Kauppinen, E., Sutinen, E., Joensuu, E., Koli, K. & Myllärniemi, M., 2018, In : International Journal of Pharmaceutics. 544, 1, p. 121-128 8 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Activities 1995 2018

External Examiner of PhD thesis

Katri Koli (Opponent)
11 Dec 2018

Activity: Examination typesPre-examiner of doctoral thesis

Supervision of Master's thesis

Katri Koli (Supervisor)
1 Apr 2018

Activity: Examination typesSupervision of other thesis (Master's, Licentiate)

Reviewing of PhD thesis

Katri Koli (Pre-examiner)
4 Jan 2017

Activity: Examination typesPre-examiner of doctoral thesis

Reviewing of PhD thesis

Katri Koli (Pre-examiner)
20 Jul 2017

Activity: Examination typesPre-examiner of doctoral thesis

Expert opinion/ title of docent

Katri Koli (Participant)
8 Nov 2016

Activity: Other activity typesOther